Your browser doesn't support javascript.
loading
Effect of IL4 and IL10 on a human in vitro type 1 diabetes model.
Pfeiffer, Susanne E M; Quesada-Masachs, Estefania; McArdle, Sara; Zilberman, Samuel; Yesildag, Burcak; Mikulski, Zbigniew; von Herrath, Matthias.
Afiliação
  • Pfeiffer SEM; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Quesada-Masachs E; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • McArdle S; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Zilberman S; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Yesildag B; InSphero, Zurich, Switzerland.
  • Mikulski Z; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • von Herrath M; La Jolla Institute for Immunology, La Jolla, CA, USA. Electronic address: matthias@lji.org.
Clin Immunol ; 241: 109076, 2022 08.
Article em En | MEDLINE | ID: mdl-35817292
We defined the effect of the anti-inflammatory cytokines IL4 and IL10 on an in vitro model of human T1D. After preincubation with IL4 or IL10, human islet microtissues were co-cultured with PBMC and proinflammatory cytokines for a few hours or for multiple days to assess acute and chronic effects. This resulted in an immune attack with infiltration of T cells into the islet, a loss of beta cell endocrine function, and an upregulation of HLA-I on the beta cells. HLA-I upregulation was associated with infiltration of T cells and both HLA-I expression and infiltration were associated with impaired insulin secretion. Preincubation with IL4 or IL10 did not preserve beta cell function but decreased infiltration of T cells. Our data support the hypothesis that a loss of beta cell endocrine function mediates an increase in beta cell specific antigen presentation. IL4 and IL10 failed to preserve beta cell endocrine function.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-10 / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-10 / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos